Active immunotherapy and alternative therapeutic modalities for Alzheimer's disease
| Autor: | Robert Alexander, Lisa J. Bain, Peter Powchik, Maria C. Carrillo, Ronald G. Crystal, Stacie Weninger, Magnus Ivarsson, C. Anthony Altar, Bjorn Sperling, Christopher J. Weber, Fiona M. Menzies, Stephen J. Haggarty, Jeanne F. Loring |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
0301 basic medicine
Government Modalities business.industry Drug target RC952-954.6 Active immunotherapy Disease medicine.disease Therapeutic modalities 03 medical and health sciences Psychiatry and Mental health 030104 developmental biology 0302 clinical medicine Geriatrics Perspective medicine Dementia Engineering ethics Neurology. Diseases of the nervous system Neurology (clinical) RC346-429 business 030217 neurology & neurosurgery Perspectives |
| Zdroj: | Alzheimer’s & Dementia: Translational Research & Clinical Interventions, Vol 6, Iss 1, Pp n/a-n/a (2020) Alzheimer's & Dementia : Translational Research & Clinical Interventions |
| ISSN: | 2352-8737 |
| Popis: | As knowledge of Alzheimer's disease (AD) progression improves, the field has recognized the need to diversify the pipeline, broaden strategies and approaches to therapies, as well as delivery mechanisms. A better understanding of the earliest biological processes of AD/dementia would help inform drug target selection. Currently there are a number of programs exploring these alternate avenues. This meeting will allow experts in the field (academia, industry, government) to provide perspectives and experiences that can help elucidate what the pipeline looks like today and what avenues hold promise in developing new therapies across the stages of AD. The focus here is on Active Immunotherapies and Alternative Therapeutic Modalities. This topic includes active vaccines, antisense oligomers, and cell‐based therapy among others, and highlights new clinical developments that utilize these modalities. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text